7728 Federal Register / Vol. 86, No. 19 / Monday, February 1, 2021 / Notices 

examples of activities consistent with 

the purposes of the authorizing 

legislation: 

• Improving and supporting remote 

work, such as the purchase of 

communications and technology 

hardware, software, or infrastructure; 

• Costs associated with establishing 

new or improving existing processes for 

responding to alleged scams and frauds, 

especially related to COVID–19 vaccine 

or cure scams; 

• Costs associated with community 

outreach; 

• Costs associated with providing 

goods and services to APS clients 

related to COVID–19; 

• Acquiring personal protection 

equipment and supplies; 

• Paying for extended hours/overtime for staff, hiring temporary staff, and 

associated personnel costs; 

• Training costs related to COVID–19; 

• Funds for travel related to or 

required by COVID–19. 

4. Assurance to provide semi-annual 

federal financial reports and annual 

program reports related to the activities 

performed. 

B. Initial Spend Plan 

An Initial Spend Plan must be 

submitted along with the Letter of 

Assurance. The Initial Spend Plan 

should outline how the state/territory 

intends to spend their allotment in 

response to the needs and challenges to 

their APS program brought about by 

COVID–19. The plan should be 

consistent with the purpose of the 

authorizing legislation and examples 

outlined above. The Initial Spend Plan 

submitted in response to this 

opportunity is considered a preliminary 

framework for how the state/territory 

will plan to spend these funds. The 

Initial Spend Plan should have the 

following format: 2–5 pages in length, 

double-spaced, with 12pt font and 1′′ 

margins, with a layout of 8.5′′ x 11′′ 

paper. 

C. DUNS Number 

All grant applicants must obtain and 

keep current a D–U–N–S number from 

Dun and Bradstreet. It is a nine-digit 

identification number, which provides 

unique identifiers of single business 

entities. The D–U–N–S number can be 

obtained from: https://iupdate.dnb.com/ 

iUpdate/viewiUpdateHome.htm. 

D. Intergovernmental Review 

Executive Order 12372, 

Intergovernmental Review of Federal 

Programs, is not applicable to these 

grant applications. 

IV. Submission Information 

1. Letter of Assurance and Initial Spend 

Plan 

To receive funding, eligible entities 

must provide a Letter of Assurance and 

an Initial Spend Plan containing all the 

information outlined in Section III A. & 

B. above. 

Letters of Assurance and the Initial 

Spend Plan should be addressed to: 

Alison Barkoff, Acting Administrator 

and Assistant Secretary for Aging, 

Administration for Community Living, 

330 C Street SW, Washington, DC 

20201. 

Letters of Assurance and the Initial 

Spend Plan should be submitted 

electronically via email to the ACL 

Regional Administrator for each state. 

The following table identifies the ACL 

regions for each state and contact 

information for each Regional 

Administrator. 

Covered states ACL regional administrator 

Region I .................. CT, MA, ME, NH, RI, VT ....................... Jennifer Throwe, Email: jennifer.throwe@acl.hhs.gov, Phone: 617–565–1158. 

Region II ................. NY, NJ, PR, VI ...................................... Kathleen Otte, Email: kathleen.otte@acl.hhs.gov, Phone: 212–264–2976. 

Region III ................ DC, DE, MD, PA, VA, WV ..................... Rhonda Schwartz, Email: rhonda.schwartz@acl.hhs.gov, Phone: 267–831– 

2329. 

Region IV ................ AL, FL, GA, KY, MS, NC, SC, TN ........ Costas Miskis, Email: Constantinos.Miskis@acl.hhs.gov, Phone: 404–562– 

7600. 

Region V ................. IL, IN, MI, MN, OH, WI .......................... Amy Wiatr-Rodriguez, Email: Amy.Wiatr-Rodriguez@acl.hhs.gov, Phone: 312– 

938–9858. 

Region VI ................ AR, LA, OK, NM, TX ............................. Derek Lee, Email: derek.lee@acl.hhs.gov, Phone: 214–767–1865. 

Region VII ............... IA, KS, MO, NE ..................................... Lacey Boven, Email: lacey.boven@acl.hhs.gov, Phone: 816–702–4180. 

Region VIII .............. CO, MT, UT, WY, ND, SD .................... Percy Devine, Email: percy.devine@acl.hhs.gov, Phone: 303–844–2951. 

Region IX ................ CA, NV, AZ, HI, GU, CNMI, AS ............ Fay Gordon, Email: Fay.Gordon@acl.hhs.gov, Phone: 415–437–8780. 

Region X ................. AK, ID, OR, WA ..................................... Louise Ryan, Email: Louise.Ryan@acl.hhs.gov, Phone: (206) 615–2299. 

2. Submission Dates and Times 

To receive consideration, Letters of 

Assurance and the Initial Spend Plan 

must be submitted by 11:59 p.m. Eastern 

Time on EST March 3, 2021. Letters of 

Assurance and the Initial Spend Plan 

should be submitted electronically via 

email and have an electronic time stamp 

indicating the date/time submitted. 

VII. Agency Contacts 

1. Programmatic Issues 

Direct programmatic inquiries to: 

Stephanie Whittier Eliason, Email: 

stephanie.whittiereliason@acl.hhs.gov, 

Phone: 202.795.7467. 

2. Submission Issues 

Direct inquiries regarding submission 

of the Letters of Assurance to the 

appropriate ACL Regional 

Administrator found in the table in 

‘‘Section IV. Submission Information.’’ 

Dated: January 27, 2021. 

Alison Barkoff, 

Acting Administrator and Assistant Secretary 

for Aging. 

[FR Doc. 2021–02091 Filed 1–29–21; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

Availability of Program Application 

Instructions for Long-Term Care 

Ombudsman Program Funds 

Title: Coronavirus Response and 

Relief Supplemental Appropriations Act 

of 2021: Grants to Enhance Capacity of 

Long-Term Care Ombudsman Programs 

to Respond to Complaints of Abuse and 

Neglect of Residents in Long-Term Care 

Facilities During the COVID–19 Public 

Health Emergency. 

Announcement Type: Initial. 

Statutory Authority: The statutory 

authority for grants under this program 

announcement is contained in Section 

Federal Register / Vol. 86, No. 19 / Monday, February 1, 2021 / Notices 7729 

712 of the Older Americans Act of 1965 

[Pub. L. 89–73] [As Amended Through 

Pub. L. 116–131, Enacted March 25, 

2020]; and Subtitle B of Title XX of the 

Social Security Act, otherwise known as 

the Elder Justice Act [Pub. L. 74–271] 

[As Amended Through Pub. L. 115–123, 

Enacted February 9, 2018] as referenced 

in the Coronavirus Response and Relief 

Supplemental Appropriations Act of 

2021. 

Catalog of Federal Domestic 

Assistance (CFDA) Number: 93.747. 

DATES: The deadline date for State 

Agencies on Aging to submit their Letter 

of Assurance for Long-Term Care 

Ombudsman Programs is 11:59 p.m. 

EST March 3, 2021. 

I. Funding Opportunity Description 

The purpose of this funding 

opportunity is to strengthen the capacity 

of State Long-Term Care Ombudsman 

programs to respond during the COVID 

public health emergency and resolve 

resident complaints about abuse and 

neglect. This funding opportunity is 

appropriated through the Coronavirus 

Response and Relief Supplemental 

Appropriations Act of 2021and 

authorized by the Elder Justice Act, 42 

U.S.C. Section 2043(a)(1)(A). 

ACL seeks plans from State Agencies 

on Aging, developed in coordination 

with the State Long-Term Care 

Ombudsman, that describe how the 

Long-Term Care Ombudsman (LTCO) 

programs will use funds to enhance 

their capacity during and related to the 

COVID public health emergency to 

respond to and resolve complaints about 

abuse and neglect. This enhancement of 

capacity can include activities described 

below. Plans for use of these grant funds 

may go above and beyond those regular 

activities planned in response to other 

funding. 

To be eligible to receive this grant, 

State Agencies on Aging must submit a 

Letter of Assurance to ACL containing 

all of the assurances required, (see 

Section III of this FRN, Eligibility 

Criteria and Other Requirements). 

The Letter of Assurance will be 

considered an Amendment to the State 

Plan on Aging and must describe the 

State LTCO plans for use of these 

supplemental funds. Examples of 

activities consistent with the purposes 

of the authorizing legislation include 

the following: 

a. Enhance Ombudsman program 

complaint investigations during the 

COVID public health emergency to 

address complaints related to abuse, 

neglect and poor care; 

b. Resume in-person visitation at such 

time as visitation is permitted, such as 

when the COVID vaccine is accessible to 

residents, facility staff, and individuals 

working for the LTCO program; 

c. Conduct education and outreach on 

abuse and neglect identification and 

prevention during the COVID public 

health emergency to residents, their 

families and facility staff; 

d. Enable travel for representatives of 

the LTCO Office to ensure all residents 

have access to a LTCO representative; 

e. Continue purchase of needed 

Personal Protective Equipment; 

f. Continue purchase of technology as 

needed; 

g. Enable participation in state-level 

‘‘strike teams’’ to address complaints 

related to care and neglect; 

h. Provide information and assistance 

on transitions from long-term care 

facilities to community-based, home 

care settings, consistent with section 

712(a)(3) of the Older Americans Act. 

II. Award Information 

1. Funding Instrument Type 

These grants are discretionary, 

supplemental grants, authorized by 

Section 2043(a)(1)A) of the Elder Justice 

Act and appropriated through the 

Coronavirus Response and Relief 

Supplemental Appropriations Act of 

2021. The State Agency on Aging will 

assure that the State LTCO uses these 

supplemental funds consistent with the 

purposes authorized by appropriations 

contained in Section 2043(a)(1)A) of the 

Elder Justice Act and the Coronavirus 

Response and Relief Supplemental 

Appropriations Act, 2021. 

2. Anticipated Total Priority Area 

Funding 

The total available funding for this 

opportunity is $4,000,000. ACL intends 

to make available, under this program 

announcement, grant awards to State 

Agencies on Aging for their Long-Term 

Care Ombudsman Programs. The period 

of performance for these grants during 

which grant activities must occur is 

estimated to commence on April 1, 2021 

and is projected to end on September 

20, 2022. 

Each State Agency on Aging is eligible 

to apply for and receive the amount of 

funding in the table below: 

State/territory Available 

amount 

Alabama ................................ $60,199 

Alaska ................................... 20,000 

Arizona .................................. 90,163 

Arkansas ............................... 36,589 

California ............................... 417,159 

Colorado ............................... 61,189 

Connecticut ........................... 45,013 

Delaware ............................... 20,000 

Dist. of Columbia .................. 20,000 

Florida ................................... 303,577 

State/territory Available 

amount 

Georgia ................................. 109,640 

Hawaii ................................... 20,000 

Idaho ..................................... 20,534 

Illinois .................................... 146,331 

Indiana .................................. 77,725 

Iowa ...................................... 38,952 

Kansas .................................. 33,840 

Kentucky ............................... 53,551 

Louisiana .............................. 53,319 

Maine .................................... 20,093 

Maryland ............................... 69,196 

Massachusetts ...................... 83,348 

Michigan ............................... 126,278 

Minnesota ............................. 66,092 

Mississippi ............................ 34,710 

Missouri ................................ 75,369 

Montana ................................ 20,000 

Nebraska .............................. 22,162 

Nevada ................................. 35,030 

New Hampshire .................... 20,000 

New Jersey ........................... 105,708 

New Mexico .......................... 25,885 

New York .............................. 233,584 

North Carolina ...................... 123,870 

North Dakota ........................ 20,000 

Ohio ...................................... 146,118 

Oklahoma ............................. 45,020 

Oregon .................................. 53,369 

Pennsylvania ........................ 169,031 

Rhode Island ........................ 20,000 

South Carolina ...................... 65,596 

South Dakota ........................ 20,000 

Tennessee ............................ 81,099 

Texas .................................... 271,783 

Utah ...................................... 26,288 

Vermont ................................ 20,000 

Virginia .................................. 97,092 

Washington ........................... 86,398 

West Virginia ........................ 25,531 

Wisconsin ............................. 72,886 

Wyoming ............................... 20,000 

American Samoa .................. 2,500 

Guam .................................... 10,000 

Northern Marianas ................ 2,500 

Puerto Rico ........................... 45,683 

Virgin Islands ........................ 10,000 

III. Eligibility Criteria and Other 

Requirements 

1. The eligible entities for this award 

are State Agencies on Aging Long-Term 

Care Ombudsman Programs 

2. Cost Sharing or Matching is not 

required. 

3. State Agencies on Aging must 

provide a Letter of Assurance that will 

be considered an Amendment to the 

State Plan on Aging no later than March 

3, 2021. The Letter of Assurance must 

contain the following: 

a. A description of specific project 

strategies that may include from among 

the following: 

i. Enhancing Ombudsman program 

complaint investigations during the 

COVID public health emergency to 

address complaints related to abuse, 

neglect and poor care; 

ii. Resuming in-person visitation at 

such time as visitation is permitted, 

7730 Federal Register / Vol. 86, No. 19 / Monday, February 1, 2021 / Notices 

such as when the COVID vaccine is 

accessible to residents, facility staff, and 

individuals working for the LTCO 

program; 

iii. Conducting education and 

outreach on abuse and neglect 

identification and prevention during the 

COVID public health emergency to 

residents, their families and facility 

staff; 

iv. Enabling travel for representatives 

of the LTCO Office to ensure all 

residents have access to an LTCO; 

v. Purchase of needed Personal 

Protective Equipment; 

vi. Purchase of technology; and 

vii. Enabling participation in statelevel ‘‘strike teams’’ to address 

complaints related to care and neglect. 

b. Assurance that these funds will 

supplement, and not supplant, existing 

funding for the State LTCO program; 

and 

c. Assurance that State Agencies on 

Aging will timely submit to ACL semiannual federal financial reports and 

annual program reports related to the 

activities performed. 

4. DUNS Number 

All grant applicants must obtain and 

keep current a D–U–N–S number from 

Dun and Bradstreet. It is a nine-digit 

identification number, which provides 

unique identifiers of single business 

entities. The D–U–N–S number can be 

obtained from: https://iupdate.dnb.com/ 

iUpdate/viewiUpdateHome.htm. 

5. Intergovernmental Review 

Executive Order 12372, 

Intergovernmental Review of Federal 

Programs, is not applicable to these 

grant applications. 

IV. Submission Information 

1. Letters of Assurance should be 

addressed to: Alison Barkoff, Acting 

Administrator and Assistant Secretary 

for Aging, Administration for 

Community Living, 330 C Street SW, 

Washington, DC 20201. 

Letters of Assurance should be 

submitted electronically via email to the 

ACL Regional Administrator for each 

state listed in the Agency Contacts 

below. 

2. Submission Dates and Times: 

To receive consideration, Letters of 

Assurance must be submitted by 11:59 

p.m. Eastern Time on March 3, 2021. 

Letters of Assurance should be 

submitted electronically via email and 

have an electronic time stamp 

indicating the date/time submitted. 

VII. Agency Contacts 

Direct inquiries regarding 

programmatic issues to Regional 

Administrators: 

Covered states ACL regional administrator 

Region I .................. CT, MA, ME, NH, RI, VT ....................... Jennifer Throwe, Email: jennifer.throwe@acl.hhs.gov, Phone: 617–565–1158. 

Region II ................. NY, NJ, PR, VI ...................................... Kathleen Otte, Email: kathleen.otte@acl.hhs.gov, Phone: 212–264–2976. 

Region III ................ DC, DE, MD, PA, VA, WV ..................... Rhonda Schwartz, Email: rhonda.schwartz@acl.hhs.gov, Phone: 267–831– 

2329. 

Region IV ................ AL, FL, GA, KY, MS, NC, SC, TN ........ Costas Miskis, Email: Constantinos.Miskis@acl.hhs.gov, Phone: 404–562– 

7600. 

Region V ................. IL, IN, MI, MN, OH, WI .......................... Amy Wiatr-Rodriguez, Email: Amy.Wiatr-Rodriguez@acl.hhs.gov, Phone: 312– 

938–9858. 

Region VI ................ AR, LA, OK, NM, TX ............................. Derek Lee, Email: derek.lee@acl.hhs.gov, Phone: 214–767–1865. 

Region VII ............... IA, KS, MO, NE ..................................... Lacey Boven, Email: lacey.boven@acl.hhs.gov, Phone: 816–702–4180. 

Region VIII .............. CO, MT, UT, WY, ND, SD .................... Percy Devine, Email: percy.devine@acl.hhs.gov, Phone: 303–844–2951. 

Region IX ................ CA, NV, AZ, HI, GU, CNMI, AS ............ Fay Gordon, Email: Fay.Gordon@acl.hhs.gov, Phone: 415–437–8780. 

Region X ................. AK, ID, OR, WA ..................................... Louise Ryan, Email: Louise.Ryan@acl.hhs.gov, Phone: (206) 615–2299. 

Dated: January 27, 2021. 

Alison Barkoff, 

Acting Administrator and Assistant Secretary 

for Aging. 

[FR Doc. 2021–02092 Filed 1–29–21; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Tenth Meeting of the National Clinical 

Care Commission 

AGENCY: Office on Women’s Health, 

Office of the Assistant Secretary for 

Health, Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: The National Clinical Care 

Commission (the Commission) will 

conduct its tenth meeting virtually on 

February 17, 2021. The Commission is 

charged to evaluate and make 

recommendations to the U.S. 

Department of Health and Human 

Services (HHS) Secretary and Congress 

regarding improvements to the 

coordination and leveraging of federal 

programs related to diabetes and its 

complications. 

DATES: The meeting will take place on 

February 17, 2021, from 1 p.m. to 

approximately 5:30 p.m. Eastern 

Standard time (EST). 

ADDRESSES: The meeting will be held 

online via webinar. To register to attend 

the meeting, please visit the registration 

website at: https://

kauffmaninc.adobeconnect.com/nccc_

feb_2021/event/event_info.html. 

FOR FURTHER INFORMATION CONTACT: 

Clydette Powell, M.D., MPH, FAAP, 

Acting Designated Federal Officer, 

National Clinical Care Commission, 

U.S. Department of Health and 

Human Services Office on Women’s 

Health, 200 Independence Ave. SW, 

7th Floor, Washington, DC 20201, 

Phone: (240) 453–8239, Email: OHQ@

hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

National Clinical Care Commission Act 

(Pub. L. 115–80) requires the HHS 

Secretary to establish the National 

Clinical Care Commission. The 

Commission consists of representatives 

of specific federal agencies and nonfederal individuals who represent 

diverse disciplines and views. The 

Commission will evaluate and make 

recommendations to the HHS Secretary 

and Congress regarding improvements 

to the coordination and leveraging of 

federal programs related to diabetes and 

its complications. 

The tenth meeting will be held 

virtually, will consist of updates from 

the Commission’s three subcommittees, 

and include another round of potential 

‘‘action plans,’’ or recommendations, 

from each subcommittee. The final 

meeting agenda will be available prior 

to the meeting at: https://health.gov/ourwork/health-care-quality/nationalclinical-care-commission/meetings. 

Public Participation at Meeting: The 

Commission invites public comment on